XIFAXAN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Rifaximin.
Product ID | 55154-6777_08ea4212-5126-48c4-8cb5-3ec2f57601ba |
NDC | 55154-6777 |
Product Type | Human Prescription Drug |
Proprietary Name | XIFAXAN |
Generic Name | Rifaximin |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2010-05-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021361 |
Labeler Name | Cardinal Health |
Substance Name | RIFAXIMIN |
Active Ingredient Strength | 550 mg/1 |
Pharm Classes | Rifamycin Antibacterial [EPC],Rifamycins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2010-05-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021361 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-05-01 |
Ingredient | Strength |
---|---|
RIFAXIMIN | 550 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
50090-2445 | XIFAXAN | rifaximin |
55154-6777 | XIFAXAN | rifaximin |
65649-301 | XIFAXAN | rifaximin |
65649-303 | XIFAXAN | rifaximin |
68151-4980 | XIFAXAN | rifaximin |
68258-1107 | XIFAXAN | RIFAXIMIN |
69189-0309 | XIFAXAN | rifaximin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XIFAXAN 78428755 2965332 Live/Registered |
ALFASIGMA S.P.A. 2004-06-02 |